Your browser doesn't support javascript.
loading
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL.
Pilichowska, Monika; Pittaluga, Stefania; Ferry, Judith A; Hemminger, Jessica; Chang, Hong; Kanakry, Jennifer A; Sehn, Laurie H; Feldman, Tatyana; Abramson, Jeremy S; Kritharis, Athena; Hernandez-Ilizaliturri, Francisco J; Lossos, Izidore S; Press, Oliver W; Fenske, Timothy S; Friedberg, Jonathan W; Vose, Julie M; Blum, Kristie A; Jagadeesh, Deepa; Woda, Bruce; Gupta, Gaurav K; Gascoyne, Randy D; Jaffe, Elaine S; Evens, Andrew M.
Afiliação
  • Pilichowska M; Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA.
  • Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Ferry JA; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Hemminger J; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH.
  • Chang H; Division of Hematology/Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Kanakry JA; Institute for Clinical Research and Health Policy Studies and the Biostatistics, Epidemiology, and Research Design Center, Tufts Medical Center, Boston, MA.
  • Sehn LH; Division of Hematology/Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Feldman T; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Abramson JS; Hackensack University Medical Center, Hackensack, NJ.
  • Kritharis A; Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Hernandez-Ilizaliturri FJ; Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Lossos IS; Roswell Park Cancer Institute, Buffalo, NY.
  • Press OW; Division of Hematology/Oncology, University of Miami School of Medicine, Miami, FL.
  • Fenske TS; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Friedberg JW; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI.
  • Vose JM; Division of Hematology/Oncology, University of Rochester, Rochester, NY.
  • Blum KA; University of Nebraska Medical Center, Omaha, NE.
  • Jagadeesh D; Division of Hematology, The Ohio State University, Columbus, OH.
  • Woda B; Cleveland Clinic, Cleveland, OH.
  • Gupta GK; Department of Pathology, University of Massachusetts Medical School, Worcester, MA; and.
  • Gascoyne RD; Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA.
  • Jaffe ES; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Evens AM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Blood Adv ; 1(26): 2600-2609, 2017 Dec 12.
Article em En | MEDLINE | ID: mdl-29296913
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article